文献速递心脑血管急症

基于机器学习的急性冠脉综合征不良事件预测(PRAISE):汇总数据集的建模研究

Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets.
PubMed 文献 · Lancet · 2021-01-01

模型区分能力良好,可能有助于ACS出院后风险分层和个体化决策。

要点

  • PRAISE评分基于出院时25个常规临床特征,预测ACS出院后1年全因死亡、心肌梗死和大出血。
  • 大出血定义为Bleeding Academic Research Consortium(BARC)3型或5型。
  • 模型训练于多大陆注册队列,外部验证来自1项RCT和3项前瞻性注册研究,共3444例。

适用人群与场景

  • 成人急性冠脉综合征(ACS)患者,来自BleeMACS和RENAMI注册队列(多大陆),用于模型训练和内部验证。
  • 外部验证队列为3444例ACS患者, pooled from a randomised controlled trial and three prospective registries。
  • 预测场景为ACS出院后1年内的全因死亡、复发性急性心肌梗死和major bleeding。

诊断标准与关键阈值

  • 主要出血结局定义:Bleeding Academic Research Consortium(BARC)3型或5型。
  • 模型输入为出院时常规评估的25个临床特征。
  • 模型性能主要指标为受试者工作特征曲线下面积(AUC)。
  • 原文未提及PRAISE评分的具体界值或启动/停止阈值。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 干预/方法:基于25个出院时常规临床特征训练不同机器学习模型,选择每个结局的最佳模型作为PRAISE评分。
  • 主要终点:1年全因死亡、心肌梗死和major bleeding(BARC 3或5型)。

证据类型、等级与局限

  • 证据类型:建模研究(机器学习),基于注册队列数据训练和内部验证,并在外部队列验证。
  • 局限:原文未明确列出局限;设计上为回顾性使用注册数据,外部验证队列来源包括RCT和前瞻性注册研究,样本量较大但未报告校准度等指标。

对床旁实践的改变

  • PRAISE评分可能有助于ACS出院后1年全因死亡、心肌梗死和大出血的风险分层,辅助临床决策。
  • 该评分基于出院时25个常规临床特征,适用人群为成人ACS患者,需在外部验证队列中进一步确认。
  • 原文未提及对急诊或ICU床旁具体操作(如用药、监测)的改变。
  • 常见陷阱:AUC反映区分能力,原文未报告校准度或决策阈值,不能直接用作治疗启动阈值。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: The accuracy of current prediction tools for ischaemic and bleeding events after an acute coronary syndrome (ACS) remains insufficient for individualised patient management strategies. We developed a machine learning-based risk stratification model to predict all-cause death, recurrent acute myocardial infarction, and major bleeding after ACS.

METHODS: Different machine learning models for the prediction of 1-year post-discharge all-cause death, myocardial infarction, and major bleeding (defined as Bleeding Academic Research Consortium type 3 or 5) were trained on a cohort of 19 826 adult patients with ACS (split into a training cohort [80%] and internal validation cohort [20%]) from the BleeMACS and RENAMI registries, which included patients across several continents. 25 clinical features routinely assessed at discharge were used to inform the models. The best-performing model for each study outcome (the PRAISE score) was tested in an external validation cohort of 3444 patients with ACS pooled from a randomised controlled trial and three prospective registries. Model performance was assessed according to a range of learning metrics including area under the receiver operating characteristic curve (AUC).

FINDINGS: The PRAISE score showed an AUC of 0·82 (95% CI 0·78-0·85) in the internal validation cohort and 0·92 (0·90-0·93) in the external validation cohort for 1-year all-cause death; an AUC of 0·74 (0·70-0·78) in the internal validation cohort and 0·81 (0·76-0·85) in the external validation cohort for 1-year myocardial infarction; and an AUC of 0·70 (0·66-0·75) in the internal validation cohort and 0·86 (0·82-0·89) in the external validation cohort for 1-year major bleeding.

INTERPRETATION: A machine learning-based approach for the identification of predictors of events after an ACS is feasible and effective. The PRAISE score showed accurate discriminative capabilities for the prediction of all-cause death, myocardial infarction, and major bleeding, and might be useful to guide clinical decision making.

来源:Lancet,查看原文。版权归原作者所有。

参考来源

  1. D'Ascenzo F, De Filippo O, Gallone G, et al. Machine learning-based prediction of adverse events following an acute coronary syndrome (PRAISE): a modelling study of pooled datasets. Lancet. 2021. PMID: 33453782. doi:10.1016/S0140-6736(20)32519-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。